Biotechnology Stock Nearly Doubled: VIR Insight Today
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesBiotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Fiserv saw an abrupt share decline after leadership news, even as the company kept its full-year outlook intact. This...
When a CFO sells a sizable chunk of stock, it can raise questions about the company's outlook. This guide breaks down...
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
When a figure headlines with trillionaire status and a big stock sale, investors want to know what it means for the s...
When a MongoDB director sells a sizable block of shares, investors pause to weigh the meaning. This article breaks do...
When a renowned activist investor signals a bold AI bet, markets take notice. Explore how billionaire Bill Ackman bet...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...